On Invalid Date, Psychemedics (NASDAQ: PMD) reported Q2 2023 earnings per share (EPS) of -$0.13, up 116.67% year over year. Total Psychemedics earnings for the quarter were -$726.00 thousand. In the same quarter last year, Psychemedics's earnings per share (EPS) was -$0.06.
On Invalid Date, Psychemedics (NASDAQ: PMD) reported Q2 2023 revenue of $5.54 million up 14.99% year over year. In the same quarter last year, Psychemedics's revenue was $6.51 million.
What was PMD's revenue growth in the past year?
As of Q3 2023, Psychemedics's revenue has grown -9.62% year over year. This is 11.51 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 1.89%. Psychemedics's revenue in the past year totalled $23.62 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.